Mantle Cell Lymphoma Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014561121
Market Monitor Global
Oct-2021
Life Sciences
102 Pages

This report contains market size and forecasts of Mantle Cell Lymphoma Treatment in Global, including the following market information:
Global Mantle Cell Lymphoma Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Mantle Cell Lymphoma Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mantle Cell Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mantle Cell Lymphoma Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Mantle Cell Lymphoma Treatment Market Segment Percentages, By Type, 2020 (%)
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others

China Mantle Cell Lymphoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Mantle Cell Lymphoma Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Mantle Cell Lymphoma Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Mantle Cell Lymphoma Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Mantle Cell Lymphoma Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Mantle Cell Lymphoma Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Mantle Cell Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mantle Cell Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mantle Cell Lymphoma Treatment Overall Market Size
2.1 Global Mantle Cell Lymphoma Treatment Market Size: 2021 VS 2027
2.2 Global Mantle Cell Lymphoma Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mantle Cell Lymphoma Treatment Players in Global Market
3.2 Top Global Mantle Cell Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Mantle Cell Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Mantle Cell Lymphoma Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Mantle Cell Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mantle Cell Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Mantle Cell Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Mantle Cell Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Mantle Cell Lymphoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Acalabrutinib
4.1.3 JCAR-017
4.1.4 JNJ-64052781
4.1.5 Acalisib
4.1.6 IGN-002
4.1.7 IMGN-529
4.1.8 AFM-11
4.1.9 Others
4.2 By Type - Global Mantle Cell Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Mantle Cell Lymphoma Treatment Revenue, 2016-2021
4.2.2 By Type - Global Mantle Cell Lymphoma Treatment Revenue, 2022-2027
4.2.3 By Type - Global Mantle Cell Lymphoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mantle Cell Lymphoma Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Mantle Cell Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Mantle Cell Lymphoma Treatment Revenue, 2016-2021
5.2.2 By Application - Global Mantle Cell Lymphoma Treatment Revenue, 2022-2027
5.2.3 By Application - Global Mantle Cell Lymphoma Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Mantle Cell Lymphoma Treatment Market Size, 2021 & 2027
6.2 By Region - Global Mantle Cell Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Mantle Cell Lymphoma Treatment Revenue, 2016-2021
6.2.2 By Region - Global Mantle Cell Lymphoma Treatment Revenue, 2022-2027
6.2.3 By Region - Global Mantle Cell Lymphoma Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Mantle Cell Lymphoma Treatment Revenue, 2016-2027
6.3.2 US Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.3.3 Canada Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.3.4 Mexico Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Mantle Cell Lymphoma Treatment Revenue, 2016-2027
6.4.2 Germany Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.3 France Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.4 U.K. Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.5 Italy Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.6 Russia Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.4.8 Benelux Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Mantle Cell Lymphoma Treatment Revenue, 2016-2027
6.5.2 China Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.5.3 Japan Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.5.4 South Korea Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.5.6 India Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Mantle Cell Lymphoma Treatment Revenue, 2016-2027
6.6.2 Brazil Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.6.3 Argentina Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Mantle Cell Lymphoma Treatment Revenue, 2016-2027
6.7.2 Turkey Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.7.3 Israel Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Mantle Cell Lymphoma Treatment Market Size, 2016-2027
6.7.5 UAE Mantle Cell Lymphoma Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Astex Pharmaceuticals, Inc.
7.1.1 Astex Pharmaceuticals, Inc. Corporate Summary
7.1.2 Astex Pharmaceuticals, Inc. Business Overview
7.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.1.4 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.1.5 Astex Pharmaceuticals, Inc. Key News
7.2 Bayer AG
7.2.1 Bayer AG Corporate Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Mantle Cell Lymphoma Treatment Major Product Offerings
7.2.4 Bayer AG Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.2.5 Bayer AG Key News
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Corporate Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.3.5 Bristol-Myers Squibb Company Key News
7.4 Celgene Corporation
7.4.1 Celgene Corporation Corporate Summary
7.4.2 Celgene Corporation Business Overview
7.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Major Product Offerings
7.4.4 Celgene Corporation Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.4.5 Celgene Corporation Key News
7.5 Cellular Biomedicine Group, Inc.
7.5.1 Cellular Biomedicine Group, Inc. Corporate Summary
7.5.2 Cellular Biomedicine Group, Inc. Business Overview
7.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.5.4 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.5.5 Cellular Biomedicine Group, Inc. Key News
7.6 Eisai
7.6.1 Eisai Corporate Summary
7.6.2 Eisai Business Overview
7.6.3 Eisai Mantle Cell Lymphoma Treatment Major Product Offerings
7.6.4 Eisai Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.6.5 Eisai Key News
7.7 EpiZyme, Inc.
7.7.1 EpiZyme, Inc. Corporate Summary
7.7.2 EpiZyme, Inc. Business Overview
7.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.4.4 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.7.5 EpiZyme, Inc. Key News
7.8 Fate Therapeutics, Inc.
7.8.1 Fate Therapeutics, Inc. Corporate Summary
7.8.2 Fate Therapeutics, Inc. Business Overview
7.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.8.4 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.8.5 Fate Therapeutics, Inc. Key News
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Corporate Summary
7.9.2 Genentech, Inc. Business Overview
7.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.9.4 Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.9.5 Genentech, Inc. Key News
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Corporate Summary
7.10.2 Gilead Sciences, Inc. Business Overview
7.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.10.4 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.10.5 Gilead Sciences, Inc. Key News
7.11 GlaxoSmithKline Plc
7.11.1 GlaxoSmithKline Plc Corporate Summary
7.11.2 GlaxoSmithKline Plc Business Overview
7.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Major Product Offerings
7.11.4 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.11.5 GlaxoSmithKline Plc Key News
7.12 Hutchison MediPharma Limited
7.12.1 Hutchison MediPharma Limited Corporate Summary
7.12.2 Hutchison MediPharma Limited Business Overview
7.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Major Product Offerings
7.12.4 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.12.5 Hutchison MediPharma Limited Key News
7.13 ImmunoGen, Inc.
7.13.1 ImmunoGen, Inc. Corporate Summary
7.13.2 ImmunoGen, Inc. Business Overview
7.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.13.4 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.13.5 ImmunoGen, Inc. Key News
7.14 Immunomedics, Inc.
7.14.1 Immunomedics, Inc. Corporate Summary
7.14.2 Immunomedics, Inc. Business Overview
7.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Major Product Offerings
7.14.4 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Revenue in Global (2016-2021)
7.14.5 Immunomedics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Mantle Cell Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Mantle Cell Lymphoma Treatment Market Drivers in Global Market
Table 3. Mantle Cell Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Mantle Cell Lymphoma Treatment in Global Market
Table 5. Top Mantle Cell Lymphoma Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Mantle Cell Lymphoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Mantle Cell Lymphoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Mantle Cell Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Mantle Cell Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mantle Cell Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE